Publications:

· Stamatović Ljiljana, Vasović S., Milović-Kovačević M., Karaferić A., Lukić V., Pupovac S. Tolerability of bevacizumab in metastatic triple-negative breast cancer (TNBC) patients: a single institution experience. BREAST, (2013), vol. 22 (Suppl. 3 ) br. , str. S50-S50 0.5

· A.Karaferić, Milović-Kovačević Marijana, Lj. Stamatović, S.Vasović, S.Pupovac, L.Pavlović. Specifičnosti karcinoma grlića materice u žena mlađe životne dobi . Kancerološka nedelja (51; 2014; Beograd). Program i zbornik radova/ 51.Kancerološka nedelja i 28. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 27-28.novembar 2014.godine). Srpsko lekarsko društvo; Kancerološka sekcija ISSN 2406-0569

· Milović-Kovačević Marijana, Lj. Stamatović, S.Vasović, A.Karaferić S.Pupovac, L.Pavlović. Specifičnosti karcinoma jajnika u pacijentkinja mlađe životne dobi . Kancerološka nedelja (51; 2014; Beograd). Program i zbornik radova/ 51.Kancerološka nedelja i 28. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 27-28 .novembar 2014.godine). Srpsko lekarsko društvo; Kancerološka sekcija ISSN 2406-0569

· J. Spasic, N. Stanic, M. Ristic, F. Djordjevic, N. Nikolic, V. Nikolic, S. Pupovac, D.Radosavljevic , Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia, Ann Oncol (2015) 26 (suppl 4): iv82 doi:10.1093 · Susnjar Snezana V, . Djokic, O, Pupovac Simonida , Mladenovic Jasmina, Gavrilovic Dusica , Long term follow up of elderly women diagnosed with breast cancer (Meeting Abstract), BREAST, (2015), vol. 24 br. , str. S75-S75 · Mladenovic Jasmina , Susnjar Snezana V , Pupovac Simonida, Djokic O, Gavrilovic Dusica . Postoperative radiotherapy in elderly patients with breast cancer: does it influence survival? (Meeting Abstract), BREAST, (2015), vol. 24 br. , str. S131-S131 · Posarac Vladan , Jevric Marko, Susnjar Snezana V , Djokic O, Pupovac Simonida, Gavrilovic Dusica . Comparison of breast cancer disease characteristics between female and male elderly patients (Meeting Abstract), BREAST, (2015), vol. 24 br. , str. S72-S72

· Simonida Pupovac1, Olivera Đokić2, Marijana Milović-Kovačević1, Andjela Karaferic1, Ljiljana Stamatovic1, Snezana Susnjar1. Karakteristike zena starije zivotne dobi dijagnostifikovanih u operabilnom stadijumu bolesti carcinoma dojke i lečenih u Institutu za onkologiju i radiologiju Srbije. Kancerološka nedelja (50; 2013; Beograd). Program i zbornik radova/ 50.Kancerološka nedelja i 27. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 28- 30.novembar 2013.godine). Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-049-4;

· Marijana Milović-Kovačević1, Snezana Susnjar1, Ivana Bozovic-Spasojevic, Zora Neskovic-Konstantinovic, Ljiljana Stamatovic1, Andjela Karaferic1, Simonida

Pupovac1, Tijana Vujasinovic, Zaki Aburabi, Dana Jovaniovic, Dusica Gavrilovic. Uticaj HER 2 statusa na lokalizaciju prvog relapsa u mladih steroid-receptor pozitivnih bolesnica sa karcinomom dojke tretiranih adjuvantnom ablacijom jajnika. Kancerološka nedelja (50; 2013; Beograd). Program i zbornik radova/ 50.Kancerološka nedelja i 27. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 28- 30.novembar 2013.godine). Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-049-4;

· Marijana Milović-Kovačević1, Simonida Bobic, The prognosis of patients with endometrial cancer is affected by obesity?, 10.1136/ijgc-2022-ESGO.323

· Pavlovic Lidija, Andjela Karaferic, Simonida Bobic, Milana Matovic, Marijana Milovic-Kovacevic, Marija Radovic, Ljiljana Stamatovic. Efikasnost olapariba kao terapije odrzavanja postignutog odgovora na platina baziranu terapiju kod rekurentnog, epitelijalnog, visoko gradusnog,karcinoma jajnika sa prisutnom somatskom i/ili germinativnom BRCA mutacijom: iskustvo centra. Kancerološka nedelja (59; 2022; Beograd). Zbornik apstrakata 59.Kancerološka nedelja i 35. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije. Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-142-2;

· Karaferic Andjela, Matovic Milana, Marijana Milovic-Kovacevic, Lidija Pavlovic, Simonida Bobic, Marija Radovic, Ljiljana Stamatovic. Bezbednosni profil bevacizumaba u lecenju karcinoma jajnika. Kancerološka nedelja (59; 2022; Beograd). Zbornik apstrakata 59.Kancerološka nedelja i 35. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije. Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-142-2;

· Marija Radovic, Lidija Pavlovic, Marijana Milovic-Kovacevic, Andjela Karaferic, Milana Matovic, Simonida Bobic, Ljiljana Stamatovic. Bezbednosni profil leka olaparib kao terapije odrzavanja kod platina-senzitivnog rekurentnog epitelijalnog karcinoma jajnika visokog gradusa sa BRCA 1/2 mutacijom: Iskustvo Instituta za onkologiju i radiologiju Srbije. Zbornik apstrakata 59.Kancerološka nedelja i 35. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije. Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-142-2;

· M.Milovic-Kovacevic, S.Bobic, A.Karaferic, L.Pavlovic, M. Matovic, B.Poparic-Bandjur. Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2? Breast Cancer at a Single Cancer Center. P082, SGBCC2023.

· Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers. Dragana Miletić, Marija Kraljević, Emir Sokolović, Majana Soč, Marijana Milović-Kovačević, Simonida Bobić, Timur Cerić, Stjepko Pleština, Semir Bešlija, Inga Marijanović. Med Sci Monit 2023; 29:e940356 :: DOI: 10.12659/MSM.940356

· Olaparib as a first-line maintenance treatment for BRCA-positive ovarian cancer patients: single-institution experience. Marijana Milovic-Kovacevic, Lidija Pavlovic, Milana Matovic, Simonida Bobic, Slobodan Kutic, Ljiljana Stamatovic. 4th Regional congress of Medical Oncology, Septembar 2023, Ljubljana, Slovenia, Book of abstracts, p 79-80

· Predicting factors for progression free survival (PFS) in breast cancer patients treated with ribociclib with endocrine therapy (ET). Cosovic Vojislav, Novakovic Teodora, Bobic Simonida, Kutic Slobodan, Mijucic Jovana, Pavlovic Lidija, Karaferic Andjela,

Matovic Milana, Milovic Kovacevic Marijana. Kancerološka nedelja (61; 2024; Beograd). Zbornik apstrakata 61.Kancerološka nedelja i 37. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije.

· Efficacy of trastuzumab emtansine (TDM1) in metastatic breast cancer depending on the duration of response to adjuvant HER2 therapy. Novakovic Teodora, Bobic Simonida, Kutic Slobodan, Mijucic Jovana, Cosovic Vojislav,Milovic Kovacevic Marijana.Kancerološka nedelja (61; 2024; Beograd). Zbornik apstrakata 61.Kancerološka nedelja i 37. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije.

· Granulosa cell tumour: 14 years expeience of a Tertiary Center in Serbia. Kutic S., Karaferic A., Pavlovic L., Matovic M., Bobic S., Novakovic T. Cosovic V., Mijucic J., Milovic Kovacevic M. Kancerološka nedelja (61; 2024; Beograd). Zbornik apstrakata 61.Kancerološka nedelja i 37. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije.

· Ribociclib-induced phototoxicity – the era of new drugs and new toxicities. Simonida Bobic, Bjana Poparic-Bandjur, Milana Matovic, Lidija Pavlovic, Marijana Milovic-Kovacevic. Serbian archives of medicine. 2024 Volume 152, Issue 11-12, Pages: 618-622. https://doi.org/10.2298/SARH240925092B

· Tolerability of olaparib in patients with BRCA1/2 mutated platinum sensitive recurrent high grade serous ovarian cancer receiving olaparib maintenance monotherapy – a single institution experience. Lidija Pavlovic, Simonida Bobic, Andjela Karaferic, Marijana Milovic Kovacevic, Ljiljana Stamatovic. Lib Oncol.2021: 49(Suppl2): 35-71, P27.

· Pathological complete response rates with dual HER2 blockade added to neodjuvant chemotherapy in breast cancer:a single institution experience. Simonida Bobic, Lidija Pavlovic, Andjela Karaferic, Marijana Milovic Kovacevic, Ljiljana Stamatovic. Lib Oncol.2021: 49(Suppl2): 35-71, P21.

· Marija Mojić, Nataša Radulović, Simonida Bobić, Sandra Radenković, Aránzazu Cruz-Adalia, Ivana Stojanović. Innate lymphoid cells: Dual roles and therapeutic opportunities in breast cancer,. Immunology Letters, Volume 276, 2025, 107051, ISSN 0165-2478, https://doi.org/10.1016/j.imlet.2025.107051.

Cinical trials:

Various randomized multicentre international phase III clinical trials and randomized bioequivalence studies

Memberships:

1. Multinational association for supportive care in cancer (MASCC)
2. European Society for Medical Oncology (ESMO)
3. Serbian Medical Society-general secretary
4. Serbian Society of Medical Oncology
5. European Association for Cancer Research (EACR)
6. Serbian Association for Cancer Research (SDIR)
7. Society of Hematologic Oncology (SOHO) – Ambassador to Serbia

Publications:

I Abstracts from International congresses /Abstract Books/:
1. Nikolić V, Josifovski J, Radosavljević D, Nikolić N, Ristić M, Djordjević F, Čavić M, Jakovljević K, Janković R, Gavrilović D:
Efficasy of the combination of Irinotecan and Cetuximab in treating patients with chemotherapy refractory metastatic colorectal cancer- preliminary results- Arch.of Gastroenterohepatology, oct 2011,Vol.28, No1-2,p.104,PP32

2. Spasić J, Krivokuća, A, Čavić, M, Jakovljević, K, Mališić E, Ristić, M, Djordjević F, Radosavljević D, Janković R.
Thymidylate synthase gene polymorphisms and lung adenocarcinoma in Serbia. 3rd European Lung Cancer Conference. J Thorac Oncol. 2012,7(6), Supplement 1:S42 (abstract id. 113P)

3. Spasić J, Stanic N, Djordjević F, Ristić M, Nikolić N, Radosavljević D.
Is there an association between the occurrence of neutropenia and neuropathy in patients with metastatic colorectal cancer treated with Folfox Ann Oncol (2013) 24 (suppl 4): iv97

4. J.Dimitrijevic , S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic. The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients admitted to Clinic for medical oncology, Instutute for oncology and radiology of Serbia. 2nd Regional Congress on Supportive Care in Oncology. Abstract book (2014)

5. Djordjevic F, Bosnjak S, Dimitrijevic J, Stanic N, Bakic N, Susnjar S. Hydromorphone SR effective and safe for the treatment of cancer dyspnea in lung cancer patients: positive preliminary results. Support Care Cancer 2015, 23 (Suppl 1): S260

6. Spasic J, Stanic,N, Ristic M, Djordjevic F , Nikolic N, Nikolic V, Pupovac S, Radosavljevic,D. (2015). Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia. Annals of Oncology. 26. 10.1093/annonc/mdv233.276.

7. Bosnjak S, Dimitrijevic J, Djordjevic F. Cancer and Chemotherapy-induced Nausea and Vomiting: A focus on olanzapine. Current Opinion in Supportive & Palliative Care (2016), 10:180–188

8. Scientific Days of the Oncology Institute, May 2017,Bucharest, Romania- abstract book: F.Djordjevic. Serbian model of integration of Palliative care into Oncology practice

9. Spasic J, Stanic N, Djordjevic F , Ristic M, Nikolić V, Radosavljevic, Davorin. (2017). Mitomycin-c (mtc) as salvage therapy for patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 28. 10.1093/annonc/mdx261.321

10. Spasic, J,Stanic, N, Djordjevic F, Jokic V Radosavljevic D (2018). P3.01-92 Blood Test Parameters as Prognostic Factors In EGFR-Mutated Non-Small Cell Lung Cancer Treated With TKIs. Journal of Thoracic Oncology. 13. S902. 10.1016/j.jtho.2018.08.1652.

11. Radosavljevic D, Spasic J, Ristic M , Nikolic V , Nikolic N, Stanic, N. , Djordjevic F, Gavrilović, Dušica. (2018). P3.01-85 Real-World Gefitinib 1st Line Treatment of Patients with Advanced NSCLC and EGFR Mutations – Serbian Single Center Experience. Journal of Thoracic Oncology. 13. S899. 10.1016/j.jtho.2018.08.1645.

12. Djordjevic F. Assessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) (2018) Clinical Lymphoma, Myeloma and Leukemia, Volume 18, S238

II Abstracts from National congresses /Abstract Books/:
1. Section of oncology of Serbian Medical Society 52 th annual meeting, abstract book: F.Djordjevic. Dyspnea in advanced cancer patients: ESMO Clinical Practice Guidelines (2015)

2. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Dyspnea in patients with lung cancer (2016)

3. 7th Serbian-French Oncology Congress, March 2016 Novi Sad, Serbia- abstract book: Morphine: Cancer Pain and Dyspnoea

4. Section of oncology of Serbian Medical Society 53 th annual meeting, abstract book: J.Dimitrijevic, S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic.The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients with melanoma admitted to Clinic for medical oncology (CMO), Instutute for oncology and radiology of Serbia (IORS) (2016)

5. Section of oncology of Serbian Medical Society 54 th annual meeting, Belgrade, Serbia, November 2017- abstract book: Djordjevic F, Stanic N, Dimitrijevic J, Spasic J, Zilic A, Bosnjak S, Radosavljevic D, Susnjar S. The efficacy and tolerability of slow release hydromorphone in the treatment of cancer dyspnea in lung cancer patients: experience from the Institute for Oncology and Radiology of Serbia

6. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Immunotherapy in the first line treatment in patient with NSCLC (2018)

III Books and Monographies/Brochures:

1. Educational brochure for patients about prevention and therapy of chemotherapy induced nausea and vomiting for Serbian Society for the Fight Against Cancer (2015)

2. Educational brochure for patients about supportive oncology for Institute for oncology and radiology of Serbia (2015)

Lectures at European meetings:

Lecturer at the 11th European Congress on Public Health in Ljubljana on November 30, 2018. Title: “The role of a Cancer Control Plan in Advancing Patient Outcomes”

Lecturer by invitation at the meeting Cost Action CA17404 “New diagnostic and therapeutic tools against multidrug resistant tumors” Belgrade, 27/28.02.2020. Title: “Targeted therapies in oncology – advantage and resistance”

Professional work in expert commissions and associations in Serbia:

For the National Guide for the Diagnosis and Treatment of Lung Cancer 2011. wrote a chapter on chemotherapy for advanced non-small cell lung cancer. For the 2012 National Guide for the Treatment and Diagnosis of Colon and Rectal Cancer. wrote a chapter on adjuvant and systemic chemotherapy for colorectal cancer.

President of the Subcommittee for Antineoplastic Medicines of the Central Committee for Medicines of the RFZO 2004-2012.

Member of the Republic Expert Commission for Oncology since 2014. and the Republican Expert Commission for Cytotoxic and Molecularly Targeted Medicines of the Ministry of Health 2015-2019. Previously, a member of the Subcommittee for Medicines of the RSK for oncology since 2008. ALIMS external expert since 2004.

Vice President of the Central Commission for Medicines of the RFZO from 2021.

Memberships in professional associations:

Member of the SLD Cancer Section since 1986. secretary of the Section 1995-2001, member of the Presidency.
Member of the Presidency of the Association of Medical Oncologists of Serbia (UMOS) since its foundation in 2005.
Member of the European Association of Medical Oncologists (ESMO) since 1996. and the American Society of Clinical Oncologists (ASCO) since 2003.
Member of the Balkan Union of Oncologists (BUON) since 1996, member of the Editorial Board of J of BUON.
Member of the Central European Cooperative Oncology Group (CECOG) since 2004

Publications and memberships:

• 2005 DSZBPR brochure – Nutrition in cancer patients
• 2022 Magazine “RAK” – Stereotaxic radiotherapy
• 2023 EANS2023 Barcelona – Gamma knife treatments of recurrent metastases after previous conducted palliative radiotherapy of the whole brain
• Member of the Serbian Medical Association and the European Association of Neurosurgeons (EANS)

Area of interest:
Radioneurosurgery

Work experience:

• Since 1999, medical oncologist, Institute of Oncology and Radiology of Serbia, Clinic for Medical Oncology, Department of Breast Cancer and Gynecology

Dr. Božović-Spasojević is the founder of Serbia’s Academic Breast Cancer Research Group and leads the national program on male breast cancer research within the European Organisation for Research and Treatment of Cancer (EORTC). She is also actively involved in fertility preservation and pregnancy planning programs for breast cancer patients, working through a specialized counseling service.

She is a co-author of Serbia’s National Guidelines for Breast Cancer Treatment and co-authored a textbook in Clinical Oncology for medical students at the University of Belgrade. In addition to numerous peer-reviewed publications, she has written a range of educational materials for cancer patients. In 2018, she was selected for the ESMO Leaders Generation Programme organized by the European Society for Medical Oncology (ESMO). She completed the Health Management Academy in Serbia (Methodes doo, FranklinCovey USA) in 2017.

Dr. Božović-Spasojević is a member of the Central Ethics Committee of Serbia and served on the Ministry of Health’s oncology working group from 2015 to 2020. She is also a board member of the National Association of Medical Oncologists of Serbia (UMOS) and currently leads the ESMO working group focused on the care of adolescents and young adults with cancer.